Akebia Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

[ad_1] Akebia to host conference call at 8:00 a.m. ET Vadadustat NDA assigned a PDUFA date of March 27, 2024 Vadadustat approved in 36 countries, including Australia and Taiwan Akebia strengthens cash position modifying Pharmakon loan Auryxia® (ferric citrate) quarterly net product revenue of $40.1 million CAMBRIDGE, Mass., Nov. 8, 2023 /PRNewswire/ — Akebia Therapeutics®, Inc….

Read More

stocks, news, data and earnings

[ad_1] 56 Mins Ago Vestas surges after third-quarter profit beat A Vestas wind turbine photographed in April 2022. Karol Serewis/Sopa Images | Lightrocket | Getty Images Shares of Vestas rallied more than 9% in morning trade after the Danish wind turbine manufacturer beat adjusted operating profit expectations. The company posted a third-quarter EBIT before special…

Read More

RTL Group Revenue Hit As Weak Ad Market Counters Streamer Growth – The Hollywood Reporter

[ad_1] Thomas Rabe CEO of Fremantle Parent Company RTL Group ©RTL Group A still-soft advertising market pulled down revenue at European broadcast giant RTL Group, Fremantle‘s parent company, which reported a 6.9 percent drop in turnover from January to September 2023 to €4.66 billion ($4.98 billion). Group CEO Thomas Rabe put the blame on “challenging…

Read More